HF

HRT Financial Portfolio holdings

AUM $24.3B
1-Year Est. Return 40.96%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+40.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$3.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,531
New
Increased
Reduced
Closed

Top Buys

1 +$599M
2 +$586M
3 +$285M
4
APH icon
Amphenol
APH
+$191M
5
JNJ icon
Johnson & Johnson
JNJ
+$142M

Top Sells

1 +$727M
2 +$441M
3 +$307M
4
TRI icon
Thomson Reuters
TRI
+$279M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$262M

Sector Composition

1 Technology 18.26%
2 Financials 8.71%
3 Healthcare 6.48%
4 Industrials 5.93%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VECO icon
2551
Veeco
VECO
$1.91B
-46,405
VEEV icon
2552
Veeva Systems
VEEV
$30.8B
-72,256
VERU icon
2553
Veru
VERU
$40.6M
-17,582
VGLT icon
2554
Vanguard Long-Term Treasury ETF
VGLT
$10.8B
-5,145
VKQ icon
2555
Invesco Municipal Trust
VKQ
$541M
-20,627
VLRS
2556
Controladora Vuela Compañía de Aviación
VLRS
$884M
-44,794
VMC icon
2557
Vulcan Materials
VMC
$34.8B
-38,252
VNT icon
2558
Vontier
VNT
$5.35B
-10,803
VOR icon
2559
Vor Biopharma
VOR
$618M
-23,729
VPL icon
2560
Vanguard FTSE Pacific ETF
VPL
$8.25B
-2,544
VPU icon
2561
Vanguard Utilities ETF
VPU
$8.59B
-5,426
VRA icon
2562
Vera Bradley
VRA
$69.6M
-61,987
VSAT icon
2563
Viasat
VSAT
$6.3B
-500,652
VSH icon
2564
Vishay Intertechnology
VSH
$2.38B
-33,501
VTAK icon
2565
Catheter Precision
VTAK
$2.78M
-9,148
VTHR icon
2566
Vanguard Russell 3000 ETF
VTHR
$4.02B
-8,737
VTLE
2567
DELISTED
Vital Energy
VTLE
-46,643
VTWG icon
2568
Vanguard Russell 2000 Growth ETF
VTWG
$1.21B
-1,827
VTWO icon
2569
Vanguard Russell 2000 ETF
VTWO
$14.1B
-33,856
VTYX
2570
DELISTED
Ventyx Biosciences
VTYX
-91,434
VUSB icon
2571
Vanguard Ultra-Short Bond ETF
VUSB
$7.99B
-53,586
VVPR icon
2572
VivoPower
VVPR
$32.9M
-10,441
VWO icon
2573
Vanguard FTSE Emerging Markets ETF
VWO
$113B
-35,631
VXRT
2574
DELISTED
Vaxart
VXRT
-178,883
VYNE icon
2575
VYNE Therapeutics
VYNE
$20M
-42,037